The Holding Company for Vaccines and Sera (Vacsera) has emphasized the critical importance of vaccinating children against varicella, commonly known as chickenpox, citing the virus’s rapid spread, particularly in communal settings.
Vacsera officials warned that despite common perceptions of chickenpox as a mild illness, complications can arise, including pneumonia, sepsis, and severe skin infections requiring immediate medical intervention and potential hospitalization. The company highlighted the particular vulnerability of children with weakened immune systems.
The warning extends beyond childhood, with Vacsera noting the significant risk chickenpox poses to pregnant women. Infection during pregnancy can lead to transmission to the fetus, resulting in serious health complications and potential birth defects. This underscores the necessity of vaccination as a protective measure for the entire family, according to the company.
Vacsera announced that the varicella vaccine is currently available at all of its vaccination centers nationwide. The vaccination schedule consists of two doses, administered three months apart, with vaccinations beginning at 12 months of age. Contraindications to the vaccine include high fever, pregnancy, and immune deficiencies.
Health experts reinforce that vaccination remains the most effective means of preventing chickenpox, especially among children. The vaccine significantly reduces the likelihood of infection and minimizes the severity of the illness should infection occur, while similarly mitigating the risk of complications. It also plays a crucial role in limiting the spread of the virus within schools and other gathering places.
According to Vacsera, the vaccine is administered in two doses: the first between 12 and 15 months of age, and the second between 4 and 6 years of age. The company stresses that adherence to the recommended vaccination schedule is vital in reducing infection rates within the broader community.